Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Fatty Liver: early-phase trial registry
4 of 21 indexed Fatty Liver trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #797 of 28,707 conditions by registered trial count.
21 US clinical trials · 4 currently recruiting · #797 of 28,707 conditions by registered trial count
Fatty Liver: 21 US clinical trials tracked, 4 recruiting.
Fatty Liver is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), running 6 of these trials.
Enrollment posture brief
Registry condition fatty-liver
OPEN 4 | RECR 19% | LATE 1 | EARLY 6 | RANK #797 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Colonoscopy (19% recruiting · 21 trials)
Fatty Liver lists 4 open slots (19% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Fatty Liver on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Fatty Liver is recruiting below its size-band peers.
4 of 21 indexed trials (19%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Fatty Liver research.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) accounts for 6 of 21 trials (28.6%). 16 distinct sponsors appear on at least one study for this condition label.
-
Most Fatty Liver trials plan to enrol fewer than 100 people.
Median target enrolment is 54 among the 21 trials that report a genuine target (sentinel values excluded). 14 of those (66.7%) plan for fewer than 100 participants.
-
Fatty Liver splits between interventional and observational designs.
13 interventional and 8 observational studies make up this index (61.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
21 total, page 1 of 1
Early Tracking of Childhood Health Determinants (ETCHED) Study
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT03481829
Blood Collection Biorepository for Liver Disease Research
State University of New York at Buffalo
NCT03025074
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Methodist Health System
NCT06225193
Intermittent Fasting for NAFLD in Adults
Massachusetts General Hospital
NCT04899102
Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis
Rivus Pharmaceuticals
NCT05979779
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
Brooke Army Medical Center
NCT01100398
Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00063635
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
Elysium Health
NCT03513523
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT02363309
Low Fat Vegan or American Heart Association Diets & Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol
The Cleveland Clinic
NCT01817491
Evaluation of Diet and Exercise in Patients With Non-Alcoholic Fatty Liver Disease
San Antonio Military Medical Center
NCT00815009
Evaluation of Liver and Cardiometabolic Health Benefits on Low Carbohydrate Ketogenic Diet
Virginia Commonwealth University
NCT03141008
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT02520609
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00862433
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00323414
Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults
Columbia University
NCT02347007
Relation of Obesity With Frequency of Meals (MST 0557)
Rockefeller University
NCT00229255
Effect of Fatty Liver on TCA Cycle Flux and the Pentose Phosphate Pathway
University of Texas Southwestern Medical Center
NCT03480594
An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis
Pinnacle Clinical Research, P
NCT03656068
Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease
Washington University School of Medicine
NCT00949403
Study of Gemcabene in Adults With FPLD
Elif Oral
NCT03508687
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Fatty Liver records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Fatty Liver trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Fatty Liver page
21 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Fatty Liver trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsors the most Fatty Liver trials on record, review their full trial history before evaluating a specific study. See National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Fatty Liver condition card totals 21 registered trials; most-linked intervention Group 3 Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.